Burlingame, CA – According to filings with the U.S. Securities and Exchange Commission, Color is raising $99,999,991.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Othman Laraki played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Color
Color is a leader in distributed healthcare and clinical testing. From high-throughput COVID-19 testing to hereditary cancer and heart disease risk testing, we provide the technology and infrastructure to power large-scale health initiatives. We work with health systems, employers, researchers, physicians and national health initiatives worldwide to drive positive health outcomes. We provide fast, accurate, COVID-19 testing and screening for large populations, with a separate high-capacity lab, an integrated infrastructure, and full program logistics. Our custom-built software and state-of-the-art, automated CAP-accredited, CLIA-certified laboratories ensure high quality at a lower cost. We believe that individuals should own and control their own genetic information. We give our clients clear control over how their data is used. Our service complies with HIPAA and other security and privacy standards.

To learn more about Color, visit http://www.color.com/

Contact:
Othman Laraki, President and Chief Executive Officer
650-651-7116

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved